Integer Holdings Co. (NYSE:ITGR) Short Interest Up 5.7% in December

Integer Holdings Co. (NYSE:ITGR - Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 2,230,000 shares, a growth of 5.7% from the November 30th total of 2,110,000 shares. Currently, 6.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 242,000 shares, the short-interest ratio is presently 9.2 days.

Integer Trading Down 0.8 %

Shares of NYSE:ITGR traded down $1.06 during midday trading on Wednesday, reaching $132.52. The company had a trading volume of 125,056 shares, compared to its average volume of 297,415. The company has a fifty day simple moving average of $135.07 and a two-hundred day simple moving average of $127.08. The firm has a market cap of $4.44 billion, a price-to-earnings ratio of 40.90, a price-to-earnings-growth ratio of 2.02 and a beta of 1.12. Integer has a 1-year low of $94.56 and a 1-year high of $142.76. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. During the same period last year, the company posted $1.27 earnings per share. The business's revenue for the quarter was up 8.7% on a year-over-year basis. Research analysts predict that Integer will post 5.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Truist Financial boosted their price target on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Wells Fargo & Company reissued an "overweight" rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Benchmark increased their price target on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, October 21st. KeyCorp boosted their price objective on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. Finally, Citigroup upped their price objective on Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $145.44.

Institutional Trading of Integer

A number of hedge funds have recently modified their holdings of ITGR. Contravisory Investment Management Inc. grew its position in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 80 shares in the last quarter. Huntington National Bank grew its holdings in shares of Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 268 shares in the last quarter. Quest Partners LLC increased its stake in shares of Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 332 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Integer by 74.1% during the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider's stock worth $85,000 after acquiring an additional 278 shares in the last quarter. Finally, Larson Financial Group LLC boosted its position in Integer by 20,000.0% during the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider's stock valued at $131,000 after purchasing an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.